from
–Shubhi Srivastava Serum Institute of India has sought permission from the Drug Controller General of India (DCGI) for the production of Russia’s COVID-19 vaccine Sputnik V. Sources said that the company has applied to DCGI for testing the vaccine. Dr Reddy’s laboratory has already got approval from the Drug Controller General of India for … Continue reading "SII sought permission from DGCI to produce Sputnik V"
The post SII sought permission from DGCI to produce Sputnik V appeared first on Gulistan News.
https://ift.tt/3z9bA1Ivia IFTTT
0 Comments